{
  "ptid_time": "007_S_4467_2012-01-23",
  "img_path": "/data/qiuhui/data/adni/images/007_S_4467/2012-01-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 12,720 mm³, 43.1% below the reference mean. With a Z-score of -1.08 (14.1th percentile), this represents mild atrophy; whole brain volume measures 1,031,600 mm³, 0.2% above the reference mean. With a Z-score of 0.03 (51.2th percentile), this represents normal volume ; entorhinal cortex volume measures 3,237 mm³, 16.8% below the reference mean. With a Z-score of -1.31 (9.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 19,458 mm³, 6.9% above the reference mean. With a Z-score of 0.77 (78.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,739 mm³, 8.7% below the reference mean. With a Z-score of -0.77 (22.0th percentile), this represents normal volume . ",
  "text_data": "Age is 61.9 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Cardiovascular; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 27.0. MoCA: 24.0. Logical Memory: 9.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.40 SUVR (significant elevated); Amyloid beta: 705.20 pg/mL (normal ); Total tau: 675.60 pg/mL (profound elevated); Phosphorylated tau: 76.51 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild atrophy in the ventricular volume and entorhinal cortex, with normal whole brain, fusiform gyrus, and middle temporal gyrus volumes. Clinically, the patient has normal Aβ but profoundly elevated T-tau and P-tau, along with significant AV45 (amyloid PET) positivity, suggesting underlying Alzheimer's pathology despite relatively preserved cognition (MMSE 27, MoCA 24).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s disease given biomarker profile).  \n\n**Confidence:** **High** (due to clear biomarker evidence of Alzheimer’s pathology and mild cognitive deficits, though structural atrophy is not yet severe).  \n\n*Note: The presence of two APOE4 alleles increases Alzheimer’s risk, and the tau/Aβ mismatch (normal Aβ but high tau) could suggest atypical AD or a tauopathy, but MCI due to AD remains the most likely diagnosis.*",
  "timestamp": "2025-07-25T22:00:36.800232"
}